Adma Biologics | ADMA - Net Income

Stock Price
9.66
Daily Change
-0.17 -1.73%
Monthly
-38.98%
Yearly
-48.29%
Q2 Forecast
8.91

Adma Biologics reported $49.38M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Adma Biologics USD 49.38M 12.95M Dec/2025
Alnylam Pharmaceuticals USD 186.42M 64.66M Dec/2025
BioCryst Pharmaceuticals USD 245.84M 232.95M Dec/2025
Minerva Neurosciences USD 1.44M 21.07M Dec/2024
Novavax USD 17.53M 219.91M Dec/2025
Omeros USD -32.23M 23.81M Sep/2024
Takeda JPY 103.64B 115.44B Dec/2025